Hayashi, Y. (2025) “Combined Impact of Prior Polatuzumab Vedotin Plus Bendamustine and Rituximab Therapy and Myeloablative Conditioning on Early Post-Transplant BK Virus-Associated Hemorrhagic Cystitis”, Journal of Hematology, 14(2), pp. 66–73. doi:10.14740/jh2010.